Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medication Management topic
No spam. Unsubscribe anytime.
Startup urges Nevada to modernize medication administration for people with IDD, cites $60M potential savings
Summary
Improve On, a medication‑management technology company, told lawmakers that automating medication administration and documentation in IDD residential settings could cut medication errors and save an estimated $60M over four years in Nevada, while returning caregiver time to direct care; presenter asked the committee to consider funding, survey workflows and engage providers before mandating solutions.
A technology vendor told the Joint Interim Standing Committee on March 31 that automating medication workflows for people with intellectual and developmental disabilities (IDD) could reduce errors, recover caregiver time and lower avoidable healthcare costs.
Justin Amoyal, founder of Improve On, outlined how community residential settings rely on manual, multi‑step medication processes managed by direct support professionals (DSPs) and said those systems are error‑prone. He described a software‑and‑optional‑device platform that guides dispensing, documents administration in real time and connects pharmacies, caregivers and state oversight systems. Amoyal presented modeling he said used Nevada population data and national claims to estimate more than $60 million in avoidable medical cost savings over four years if modern medication management were widely deployed.
Why it matters: Amoyal said medication mismanagement contributes to hospitalizations, repeat emergency visits and worsened outcomes for people with IDD, and that automating documentation could also save staff time—estimating 1.2 hours per day per DSP, yielding thousands of work hours across the state.
Context and safeguards: Amoyal emphasized his testimony was not a sales pitch to adopt a single product; he asked the committee to treat this as an operational problem that requires subject matter expertise and to use planning dollars or pilot projects to assess needs and costs. He referenced national case studies—including a South Carolina provider that recorded 23,643 administrations in one month without errors after adopting digital medication management—and said several states, including Massachusetts, have begun similar deployments.
Questions from lawmakers focused on whether Improve On sought procurement or funding and how the system would integrate with existing training and AB 78‑driven medication administration work. Amoyal replied he was not asking for a direct state purchase; rather, he asked legislators to consider how funding for IDD services (including providers and state surveyors) could support pilots, and that his company would help with outreach, training and implementation if selected.
The committee took no formal vote; members asked follow‑up on cost ranges, how devices integrate with pharmacies and whether the platform requires mandates. Amoyal said pricing varies by population served and that the company prefers voluntary adoption aided by outreach and technical assistance rather than mandates.
